DVA - NYSE

DaVita Inc.

DVA·NYSE

$195.03

+3.8%

HealthcareMedical - Care Facilities

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$12.52B

EPS9.7200

P/E Ratio20.06

Earnings Date08/04/2026

17.48B

Assets

3Y+3.0%

5Y+3.0%

10Y-7.0%

16.32B

Total Liabilities

3Y+11.0%

5Y+16.0%

10Y+26.0%

1.16B

Total Equity

-45%

3Y-48.0%

5Y-60.0%

10Y-80.0%

DaVita Inc. Funding & Solvency Profile

DVA · NYSE

Current Assets

Cash & Cash Equivalents757.75M

Net Receivables2.96B

Inventory160.63M

Other Current Assets156.28M

Total Current Assets4 B

Non-Current Assets

Property, Plant & Equipment5.21B

Goodwill & Intangible Assets7.77B

Long-Term Investments198.22M

Other Non-Current Assets246.52M

Total Non-Current Assets6 B

Total Assets

17.48B

Financial Health Analysis

Current Ratio

1.29x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

14.09x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

916 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

23% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

DaVita Inc. Balance Sheet

DVA • NYSE

DaVita Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	757.7M	794.9M	380.1M	244.1M	461.9M	325M	1.1B	323M	508.2M	674.8M	1.5B	965.2M	946.2M	533.7M	393.8M	860.1M	539.5M	410.9M	447M	310.2M
Short-Term Investments	24.3M	51.1M	11.6M	77.7M	22.3M	20.1M	11.6M	2.9M	43.5M	310.2M	408.1M	337.4M	6.8M	7.1M	17.4M	23M	26.5M	35.5M	40.3M	0.0
Cash & Short-Term Investments	782.1M	846M	391.7M	321.8M	484.2M	345.1M	1.1B	326M	541.1M	981.8M	1.9B	1.3B	953.1M	540.9M	411.2M	883.1M	565.9M	446.4M	487.3M	314.9M
Net Receivables	3B	2.6B	2.4B	2.6B	2.4B	1.8B	1.8B	1.9B	1.7B	1.5B	1.7B	1.5B	1.5B	1.4B	1.5B	1.4B	1.4B	1.3B	1.1B	1.1B
Accounts Receivables	2.4B	2.1B	2B	2.1B	2B	1.8B	1.8B	1.9B	1.7B	1.5B	1.7B	1.5B	1.5B	1.4B	1.2B	1B	1.1B	1.1B	927.9M	932.4M
Other Receivables	544.4M	410.7M	429.1M	418.6M	452.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	269.8M	304.4M	263.5M	239.2M	198.7M	148.8M
Inventory	160.6M	134.6M	143.1M	109.1M	107.4M	111.6M	97.9M	107.4M	181.8M	164.9M	185.6M	136.1M	88.8M	78.1M	75.7M	76M	70M	84.2M	80.2M	89.1M
Prepaids	0.0	0.0	0.0	0.0	72.5M	76.4M	66.9M	111.8M	104.7M	96.8M	105.2M	102.5M	93.9M	0.0	48.3M	0.0	0.0	-32.1M	0.0	0.0
Other Current Assets	156.3M	207.8M	187.2M	173.7M	93.1M	791.4M	615.8M	6B	6.2B	6.5B	580.5M	569.1M	851.4M	843.7M	281.5M	270.1M	297.2M	251M	282.1M	224.2M
Total Current Assets	4.1B	3.7B	3.1B	3.2B	3.2B	3.1B	3.7B	8.4B	8.7B	4B	4.5B	3.9B	3.5B	2.9B	2.3B	2.6B	2.3B	2.1B	2B	1.7B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	5.2B	5.3B	5.6B	5.9B	6.3B	6.4B	6.3B	3.4B	3.1B	3.2B	2.8B	2.5B	2.2B	1.9B	1.4B	1.2B	1.1B	1B	939.3M	850M
Goodwill	7.5B	7.4B	7.1B	7.1B	7B	6.9B	6.8B	6.8B	6.6B	9.4B	9.3B	9.4B	9.2B	9B	4.9B	4.1B	4B	3.9B	3.8B	3.7B
Intangible Assets	222.1M	197.4M	203.2M	182.7M	177.7M	166.6M	135.7M	118.8M	113.8M	1.5B	1.7B	1.9B	2B	2.1B	159.5M	162.6M	136.7M	160.5M	183M	203.7M
Goodwill & Intangible Assets	7.8B	7.6B	7.3B	7.3B	7.2B	7.1B	6.9B	7B	6.7B	10.9B	11B	11.4B	11.2B	11.1B	5.1B	4.3B	4.1B	4B	4B	3.9B
Long-Term Investments	198.2M	370.3M	593.7M	275.4M	288.4M	289.7M	278.5M	260M	283.2M	606.1M	167.5M	155M	120.2M	94.5M	37.2M	34.8M	30.2M	25M	42M	15M
Other Non-Current Assets	246.5M	261.7M	271.3M	315.6M	136.7M	79.5M	116M	71.6M	47.3M	5.3B	73.6M	77M	79.6M	79.9M	34.2M	32.1M	32.6M	47.3M	77.4M	60.8M
Total Non-Current Assets	13.4B	13.5B	13.8B	13.8B	14B	13.8B	13.6B	10.7B	10.2B	14.8B	14B	14B	13.6B	13.1B	6.6B	5.5B	5.3B	5.2B	5B	4.8B
Other Assets	0.0	0.0	0.0	1K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	17.5B	17.3B	16.9B	16.9B	17.1B	17B	17.3B	19.1B	18.9B	18.7B	18.5B	17.9B	17.1B	16B	8.9B	8.1B	7.6B	7.3B	6.9B	6.5B
LIABILITIES
CURRENT LIABILITIES
Total Payables	720.5M	616.5M	590.4M	540.6M	497.6M	481.1M	482.5M	491.9M	537.4M	481.7M	929M	825.6M	772.5M	710.8M	342.2M	181M	199.7M	282.9M	225.5M	251.7M
Accounts Payable	696.1M	547.2M	514.5M	479.8M	402M	434.3M	403.8M	463.3M	509.1M	456.6M	514M	445.5M	435.5M	414.1M	289.7M	181M	176.7M	282.9M	225.5M	251.7M
Other Payables	24.4M	69.3M	75.9M	60.8M	95.6M	46.8M	78.7M	28.7M	28.3M	25M	415.1M	380.1M	337M	296.6M	52.6M	0.0	23.1M	0.0	0.0	0.0
Accrued Expenses	793.5M	143.6M	110.3M	102.6M	88.5M	84.5M	113.8M	141.4M	148.3M	159.1M	161.9M	180.2M	130.5M	123M	90.3M	325.5M	286.1M	312.2M	395.9M	341.8M
Short Term Debt	109.2M	270.9M	123.3M	231.4M	179M	168.5M	130.7M	1.9B	178.2M	160.3M	129M	120.2M	274.7M	227.8M	87.3M	74.9M	100M	72.7M	23.4M	20.9M
Capital Lease Obligations (Current)	425.5M	410.4M	394.4M	395.4M	394.4M	369.5M	343.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	69.3M	28.5M	18M	53.8M	7.8M	42.4M	28.7M	28.3M	27.8M	29.3M	25.9M	18.4M	18M	37.4M	0.0	23.1M	0.0	16.5M	24.6M
Other Current Liabilities	1.1B	1.5B	1.4B	1.3B	1.2B	1.4B	1.3B	2.3B	2.2B	1.9B	1.2B	962.8M	1.3B	949.6M	644.9M	342.9M	461.1M	495.2M	441.8M	497.8M
Total Current Liabilities	3.1B	3B	2.6B	2.6B	2.4B	2.5B	2.4B	4.9B	3B	2.7B	2.4B	2.1B	2.5B	2B	1.2B	924.3M	1B	1.2B	1.1B	1.1B
NON-CURRENT LIABILITIES
Long Term Debt	12.3B	9.2B	8.3B	8.7B	8.7B	7.9B	8B	8.2B	9.2B	8.9B	9B	8.3B	8.1B	8.3B	4.4B	4.2B	3.5B	3.7B	3.7B	3.7B
Deferred Tax Liabilities (Non-Current)	756.9M	665.4M	726.2M	782.8M	831M	809.6M	577.5M	562.5M	486.2M	809.1M	727M	890.7M	812.4M	715.2M	423.1M	421.4M	334.9M	244.9M	166.1M	125.6M
Other Non-Current Liabilities	-2.1B	169.6M	183.1M	105.2M	119.2M	150.1M	160.8M	450.7M	365.3M	746.3M	439.2M	389.8M	380.3M	458.4M	152M	497.7M	450.1M	392.8M	124.8M	155.3M
Total Non-Current Liabilities	13.2B	12.2B	11.5B	12.1B	12.4B	11.6B	11.4B	9.2B	10B	10.2B	10.2B	9.3B	9.3B	9.5B	5B	5.2B	4.3B	4.3B	4B	4B
Capital Lease Obligations	2.6B	2.6B	2.7B	2.9B	3.1B	3.1B	3.1B	246M	261.9M	0.0	267.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	16.3B	15.2B	14.2B	14.7B	14.8B	14.1B	13.8B	14.1B	13.1B	12.9B	12.6B	11.4B	11.8B	11.5B	6.2B	6.1B	5.4B	5.5B	5.1B	5.1B
SHAREHOLDERS' EQUITY
Treasury Stock	-199.9M	-1.4B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-544.8M	0.0	0.0	-1.2B	-1.6B	-1.4B	-793.3M	-691.9M	-487.7M	-526.9M
Common Stock	69K	90K	89K	90K	97K	110K	126K	166K	182K	195K	217K	216K	213K	135K	135K	135K	135K	135K	135K	135K
Additional Paid-In Capital	0.0	286.3M	509.8M	606.9M	540.3M	597.1M	749M	995M	1B	1B	1.1B	1.1B	1.1B	1.2B	596.3M	620.5M	621.7M	769.1M	707.1M	630.1M
Retained Earnings	-328.4M	1.5B	598.3M	174.5M	354.3M	852.5M	1.4B	2.7B	3.6B	3.7B	4.4B	4.1B	3.4B	3.7B	3.2B	2.7B	2.3B	1.9B	1.5B	1.1B
Accumulated Other Comprehensive Income/Loss	-122.8M	-310.8M	-52.1M	-69.2M	-139.2M	-66.2M	-47.5M	-34.9M	13.2M	-89.6M	-59.8M	-25M	-2.6M	-15.3M	-19.5M	503K	-5.5M	-14.3M	-2.5M	13M
Total Stockholders' Equity	-651.1M	121.1M	1.1B	712.3M	755.5M	1.4B	2.1B	3.7B	4.7B	4.6B	4.9B	5.2B	4.4B	3.8B	2.1B	2B	2.1B	2B	1.7B	1.2B
Total Equity	1.2B	2.1B	2.7B	2.2B	2.4B	2.9B	3.5B	5B	5.9B	5.8B	5.9B	6.2B	5.3B	4.5B	2.3B	2B	2.2B	2.1B	1.9B	1.4B
Minority Interest	1.8B	2B	1.7B	1.5B	1.6B	1.5B	1.4B	1.3B	1.2B	1.2B	1.1B	1B	870.4M	745.6M	127.1M	58.7M	59.1M	165.8M	150.5M	122.4M
SUMMARY
Total Liabilities & Equity	17.5B	17.3B	16.9B	16.9B	17.1B	17B	17.3B	19.1B	18.9B	18.7B	18.5B	17.9B	17.1B	16B	8.9B	8.1B	7.6B	7.3B	6.9B	6.5B
Total Investments	222.5M	421.4M	605.3M	353.1M	310.7M	309.8M	290.1M	263M	326.7M	916.3M	575.6M	492.4M	127M	101.6M	54.6M	57.8M	56.7M	60.5M	82.3M	15M
Total Debt	15B	12.1B	11.1B	11.8B	12B	11.2B	11.2B	10.1B	9.3B	9.1B	9.1B	8.5B	8.4B	8.6B	4.5B	4.3B	3.7B	3.7B	3.7B	3.8B
Net Debt	14.3B	11.3B	10.7B	11.6B	11.5B	10.9B	10.1B	9.8B	8.8B	8.2B	7.6B	7.5B	7.5B	8B	4.1B	3.5B	3.1B	3.3B	3.3B	3.4B
Shares Outstanding	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000	70,600,000

SEC Filings

DVA - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	April 22, 2026	December 31, 2025	2025	View Filing
10-K 10-K 2025 FY FY	February 11, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 02, 2026	February 02, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 25, 2025	November 24, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 29, 2025	October 29, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	October 29, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 20, 2025	August 20, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 05, 2025	June 30, 2025	2025	View Filing

Showing 1 to 10 of 525 filings

Related Guides

Blog Categories

Continue your DVA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.